Bronchopulmonary Dysplasia
📧 Sign up to get email alerts when something new happens for Bronchopulmonary Dysplasia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-12-10Clinical Trial Update: Effective Approaches & Strategies to Ease Off Nasal CPAP In Preterm Infants [NA]
A completed clinical trial investigating strategies to ease off nasal CPAP in preterm infants with neonatal respiratory distress syndrome an…
-
CLINICAL_TRIALS trial_result · 2021-12-07Clinical Trial Update: Late Surfactant After a Recruitment Maneuver in Extremely Low Gestational Age Newborns - LATE-REC-SURF Trial [Phase 2]
Phase 2 clinical trial evaluating late surfactant after a recruitment maneuver in extremely preterm infants with bronchopulmonary dysplasia …
-
CLINICAL_TRIALS trial_result · 2021-11-02Clinical Trial Update: Autologous Cord Blood Mononuclear Cells for Bronchopulmonary Dysplasia in Very Preterm Neonates [Phase 2]
Phase 2 clinical trial evaluating autologous cord blood mononuclear cells for bronchopulmonary dysplasia in very preterm neonates has comple…
-
CLINICAL_TRIALS trial_result · 2021-10-25Clinical Trial Update: Enteral L Citrulline Supplementation in Preterm Infants - Safety, Efficacy and Dosing [Phase 1]
Phase 1 trial evaluating safety, efficacy, and dosing of enteral L-citrulline supplementation in preterm infants with bronchopulmonary dyspl…
-
CLINICAL_TRIALS trial_result · 2021-10-12Clinical Trial Update: A Safety Study of IV Stem Cell-derived Extracellular Vesicles (UNEX-42) in Preterm Neonates at High Risk for BPD [Phase 1]
Phase 1 safety study of IV stem cell-derived extracellular vesicles (UNEX-42) in preterm neonates at high risk for bronchopulmonary dysplasi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-10-08Clinical Trial Update: Effect of Autologous Cord Blood Mononuclear Cells for Treatment of Bronchopulmonary Dysplasia in Extremely Preterm Neonates [Phase 3]
Phase 3 trial evaluating autologous cord blood mononuclear cells for treatment of bronchopulmonary dysplasia in extremely preterm neonates.
-
CLINICAL_TRIALS trial_result · 2021-09-13Clinical Trial Update: Intratracheal Budesonide With Surfactant to Prevent Bronchopulmmonary Dysplasia. [Phase 3]
Phase 3 trial evaluating intratracheal budesonide with surfactant to prevent bronchopulmonary dysplasia in premature infants; status current…
-
CLINICAL_TRIALS trial_result · 2021-08-03Clinical Trial Update: Early Caffeine in Preterm Neonates [Phase 4]
A Phase 4 clinical trial update on early caffeine use in preterm neonates for bronchopulmonary dysplasia and apnea of prematurity; current s…
-
CLINICAL_TRIALS trial_result · 2021-05-13Clinical Trial Update: Trial of Late Surfactant for Prevention of Bronchopulmonary Dysplasia [Phase 3]
Phase 3 trial evaluating late surfactant to prevent bronchopulmonary dysplasia has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Randomized Controlled Trial to Evaluate the Safety and Efficacy of Acetaminophen in Preterm Infants Used in Combination With Ibuprofen for Closure of the Ductus Arteriosus [Phase 2]
Phase 2 randomized trial evaluating safety and efficacy of acetaminophen with ibuprofen for closing the ductus arteriosus in preterm infants…
-
CLINICAL_TRIALS trial_result · 2021-03-12Clinical Trial Update: Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2) [Phase 2]
Phase 2 trial update presenting multi-dose pharmacokinetics and dose-ranging of inositol in premature infants; results posted after completi…
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: Treatment of Classic Mid-trimester PPROM by Means of Continuous Amnioinfusion [Phase 3]
Phase 3 clinical trial update on continuous amnioinfusion for treatment of classic mid-trimester preterm premature rupture of membranes (PPR…
-
CLINICAL_TRIALS trial_result · 2020-06-02Clinical Trial Update: Autologous Cord Blood Cells for Prevention of BPD in Preterm [Phase 2]
A Phase 2 trial evaluating autologous cord blood cells to prevent bronchopulmonary dysplasia in preterm infants has completed.
-
CLINICAL_TRIALS trial_result · 2020-05-01Clinical Trial Update: OPTIMIST-A Trial: Minimally-invasive Surfactant Therapy in Preterm Infants 25-28 Weeks Gestation on CPAP [Phase 4]
A Phase 4 trial update on minimally-invasive surfactant therapy for preterm infants 25-28 weeks on CPAP, investigating prevention or managem…
-
CLINICAL_TRIALS trial_result · 2020-03-26Clinical Trial Update: GER Poses a Potential Risk for Late Complications of BPD
Clinical trial update suggests GER may be associated with late complications of bronchopulmonary dysplasia; results have been posted.
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: No Treatment Versus Oral Ibuprofen Treatment for Patent Ductus Arteriosus in Preterm Infants [Phase 2]
Phase 2 trial comparing no treatment to oral ibuprofen for patent ductus arteriosus in preterm infants; study completed.
-
CLINICAL_TRIALS trial_result · 2019-09-10Clinical Trial Update: Efficacy of Recombinant Human Clara Cell 10 Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome [Phase 2]
Phase 2 trial assessing recombinant human Clara Cell 10 Protein (rhCC10) for respiratory distress syndrome in premature neonates; results ha…
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: Efficacy and Safety Evaluation of Pneumostem® Versus a Control Group for Treatment of BPD in Premature Infants [Phase 2]
Phase 2 trial update evaluating Pneumostem® vs control for bronchopulmonary dysplasia in premature infants, focusing on efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2019-08-15Clinical Trial Update: Zinc Supplementation on Very Low Birth Weight Infant [Phase 4]
Phase 4 trial evaluating zinc supplementation in very low birth weight infants with various neonatal conditions; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2019-08-07Clinical Trial Update: Efficacy of Adding Budesonide to Poractant Alfa to Prevent Bronchopulmonary Dysplasia. [Phase 4]
Phase 4 trial update evaluating whether adding budesonide to poractant alfa reduces bronchopulmonary dysplasia in premature infants.
-
CLINICAL_TRIALS trial_result · 2019-07-30Clinical Trial Update: Aerosolized Albuterol Use in Severe BPD [NA]
A completed clinical trial evaluating aerosolized albuterol use in infants with severe bronchopulmonary dysplasia.
-
CLINICAL_TRIALS trial_result · 2019-07-17Clinical Trial Update: Budesonide With Intratracheal Surfactants in Extremely Preterm Infants [Phase 1, Phase 2]
Phase 1/2 trial evaluating budesonide with intratracheal surfactants in extremely preterm infants to address bronchopulmonary dysplasia and …
-
CLINICAL_TRIALS trial_result · 2019-05-23Clinical Trial Update: Preterm Infant Inhaled Albuterol Dosing [Phase 4]
Phase 4 trial update on inhaled albuterol dosing in preterm infants with bronchopulmonary dysplasia and very low birth weight.
-
CLINICAL_TRIALS trial_result · 2019-03-22Clinical Trial Update: Dexamethasone Therapy in VLBW Infants at Risk of CLD [Phase 3]
Phase 3 clinical trial evaluating dexamethasone therapy in very low birth weight infants at risk of bronchopulmonary dysplasia has completed…
-
CLINICAL_TRIALS trial_result · 2019-03-22Clinical Trial Update: Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome [Phase 2, Phase 3]
Clinical trial update comparing Exosurf Neonatal and Survanta for respiratory distress syndrome in newborns, spanning Phase 2 and Phase 3, w…